These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 547012)
21. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731 [TBL] [Abstract][Full Text] [Related]
22. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243 [TBL] [Abstract][Full Text] [Related]
23. Comparative theobromine metabolism in five mammalian species. Miller GE; Radulovic LL; DeWit RH; Brabec MJ; Tarka SM; Cornish HH Drug Metab Dispos; 1984; 12(2):154-60. PubMed ID: 6144479 [TBL] [Abstract][Full Text] [Related]
24. Comparative metabolic disposition of [1-Me14C]caffeine in rats, mice, and Chinese hamsters. Arnaud MJ Drug Metab Dispos; 1985; 13(4):471-8. PubMed ID: 2863113 [TBL] [Abstract][Full Text] [Related]
25. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
26. Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6- toluene diisocyanate. Lind P; Dalene M; Skarping G; Hagmar L Occup Environ Med; 1996 Feb; 53(2):94-9. PubMed ID: 8777457 [TBL] [Abstract][Full Text] [Related]
27. [Absorption, distribution, excretion, and metabolism of 14C-miloxacin in female rats (author's transl)]. Yoshitake A; Kawahara K; Izawa A; Shono F Radioisotopes; 1980 Aug; 29(8):377-81. PubMed ID: 7208993 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Distribution of the metabolites in each species. Bieder A; Decouvelaere B; Gaillard C; Depaire H; Heusse D; Ledoux C; Lemar M; Le Roy JP; Raynaud L; Snozzi C Arzneimittelforschung; 1983; 33(9):1289-97. PubMed ID: 6685510 [TBL] [Abstract][Full Text] [Related]
29. Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats. Sprague CL; Elfarra AA Chem Res Toxicol; 2004 Jun; 17(6):819-26. PubMed ID: 15206903 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629 [TBL] [Abstract][Full Text] [Related]
31. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration. Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153 [TBL] [Abstract][Full Text] [Related]
32. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of 2,2',4,4'-tetrabromodiphenyl ether in rat and mouse. Orn U; Klasson-Wehler E Xenobiotica; 1998 Feb; 28(2):199-211. PubMed ID: 9522443 [TBL] [Abstract][Full Text] [Related]
34. Effects of age and dose on disposition and metabolism of salicylic acid in male Fischer 344 rats. McMahon TF; Diliberto JJ; Birnbaum LS Drug Metab Dispos; 1990; 18(4):494-503. PubMed ID: 1976074 [TBL] [Abstract][Full Text] [Related]
35. Exposure to toluenediamines from polyurethane-covered breast implants. Sepai O; Henschler D; Czech S; Eckert P; Sabbioni G Toxicol Lett; 1995 May; 77(1-3):371-8. PubMed ID: 7618164 [TBL] [Abstract][Full Text] [Related]
36. A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. Luu HM; Hutter JC; Bushar HF Environ Health Perspect; 1998 Jul; 106(7):393-400. PubMed ID: 9637796 [TBL] [Abstract][Full Text] [Related]
38. Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants. Hester TR; Ford NF; Gale PJ; Hammett JL; Raymond R; Turnbull D; Frankos VH; Cohen MB Plast Reconstr Surg; 1997 Oct; 100(5):1291-8. PubMed ID: 9326795 [TBL] [Abstract][Full Text] [Related]
39. Effect of phenobarbital pretreatment on the toxicity and metabolism of 2,4-diaminoanisole. Ruchirawat M; Grantham PH; Benjamin T; Weisburger EK Biochem Pharmacol; 1981 Oct; 30(19):2715-8. PubMed ID: 7295355 [No Abstract] [Full Text] [Related]
40. Percutaneous absorption and elimination of an aromatic hair dye. Frenkel EP; Brody F Arch Environ Health; 1973 Dec; 27(6):401-4. PubMed ID: 4752703 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]